A Moroni1, L Savarino, M Hoque, M Cadossi, N Baldini. 1. Department II of Orthopaedics and Traumatology, Bologna University, Rizzoli Orthopaedic Institute, Via G C Pupilli 1, 40136 Bologna, Italy. a.moroni@ior.it
Abstract
BACKGROUND: Metal-on-metal Birmingham hip resurfacing (MOM-BHR) is an alternative to metal-on-metal total hip arthroplasty (MOM-THA), especially for young and/or active patients. However, wear resulting in increased serum ion levels is a concern. QUESTIONS/PURPOSES: We asked whether (1) serum chromium (Cr), cobalt (Co), and molybdenum (Mo) concentrations would differ between patients with either MOM-BHR or MOM-THA at 5 years, (2) confounding factors such as gender would influence ion levels; and (3) ion levels would differ at 2 and 5 years for each implant type. PATIENTS AND METHODS: Ions were measured in two groups with either MOM-BHR (n = 20) or MOM-THA (n = 35) and a mean 5-year followup, and two groups with either MOM-BHR (n = 15) or MOM-THA (n = 25) and a mean 2-year followup. Forty-eight healthy blood donors were recruited for reference values. RESULTS: At 5 years, there were no differences in ion levels between patients with MOM-BHR or MOM-THA. Gender was a confounding factor, and in the MOM-BHR group at 5 years, Cr concentrations were greater in females compared with those of males. Mean ion levels were similar in patients with 2 and 5 years of followup for each implant type. Ion levels in patients were sevenfold to 10-fold higher than in controls. CONCLUSIONS: As the metal ion concentrations in the serum at 5 years were in the range reported in the literature, we do not believe concerns regarding excessive metal ion levels after MOM-BHR are justified. LEVEL OF EVIDENCE: Level III, therapeutic study. See the Guidelines for Authors for a complete description of level of evidence.
BACKGROUND:Metal-on-metal Birmingham hip resurfacing (MOM-BHR) is an alternative to metal-on-metal total hip arthroplasty (MOM-THA), especially for young and/or active patients. However, wear resulting in increased serum ion levels is a concern. QUESTIONS/PURPOSES: We asked whether (1) serum chromium (Cr), cobalt (Co), and molybdenum (Mo) concentrations would differ between patients with either MOM-BHR or MOM-THA at 5 years, (2) confounding factors such as gender would influence ion levels; and (3) ion levels would differ at 2 and 5 years for each implant type. PATIENTS AND METHODS: Ions were measured in two groups with either MOM-BHR (n = 20) or MOM-THA (n = 35) and a mean 5-year followup, and two groups with either MOM-BHR (n = 15) or MOM-THA (n = 25) and a mean 2-year followup. Forty-eight healthy blood donors were recruited for reference values. RESULTS: At 5 years, there were no differences in ion levels between patients with MOM-BHR or MOM-THA. Gender was a confounding factor, and in the MOM-BHR group at 5 years, Cr concentrations were greater in females compared with those of males. Mean ion levels were similar in patients with 2 and 5 years of followup for each implant type. Ion levels in patients were sevenfold to 10-fold higher than in controls. CONCLUSIONS: As the metal ion concentrations in the serum at 5 years were in the range reported in the literature, we do not believe concerns regarding excessive metal ion levels after MOM-BHR are justified. LEVEL OF EVIDENCE: Level III, therapeutic study. See the Guidelines for Authors for a complete description of level of evidence.
Authors: L Savarino; S Stea; D Granchi; M Visentin; G Ciapetti; M E Donati; G Rollo; G Zinghi; A Pizzoferrato; L Montanaro; A Toni Journal: J Biomed Mater Res Date: 2000-04
Authors: Nick Bayley; Habeeb Khan; Paul Grosso; Thomas Hupel; David Stevens; Matthew Snider; Emil Schemitsch; Paul Kuzyk Journal: Clin Orthop Relat Res Date: 2015-02 Impact factor: 4.176
Authors: Gabrielle S Donahue; Viktor Lindgren; Vincent P Galea; Rami Madanat; Orhun Muratoglu; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2016-04-27 Impact factor: 4.176
Authors: James P Yoon; Michel J Le Duff; Alicia J Johnson; Karren M Takamura; Edward Ebramzadeh; Harlan C Amstutz Journal: Clin Orthop Relat Res Date: 2012-11-27 Impact factor: 4.176
Authors: W Maurer-Ertl; J Friesenbichler; P Sadoghi; M Pechmann; M Trennheuser; A Leithner Journal: BMC Musculoskelet Disord Date: 2012-04-11 Impact factor: 2.362
Authors: Christopher Jantzen; Henrik L Jørgensen; Benn R Duus; Sune L Sporring; Jes B Lauritzen Journal: Acta Orthop Date: 2013-04-18 Impact factor: 3.717